04 oct
|
AstraZeneca
|
Barcelona
04 oct
AstraZeneca
Barcelona
Alexion, Astra Zeneca Rare Disease is seeking a Director of General Value Access and Pricing to shape global value, access, and pricing strategies for Haematology indications, with a focus on PNH and HSCT-TMA. The role involves launching strategies, lifecycle management, and collaboration with GMMA and country teams. The candidate will lead evidence-generation plans, navigate HTA systems, and drive payer negotiations across priority markets, ensuring patient access and aligning with enterprise #J-18808-Ljbffr
📌 Global haematology value & pricing lead – pnh (Barcelona)
🏢 AstraZeneca
📍 Barcelona